title: Inhibition of human papillomavirus type 16 E7 phosphorylation by the S100 MRP-8/14 protein complex.
abstract: The human papillomavirus type 16 (HPV16) E7 is a major viral oncoprotein that is phosphorylated by casein kinase II (CKII). Two S100 family calcium-binding proteins, macrophage inhibitory-related factor protein 8 (MRP-8) and MRP-14, form a protein complex, MRP-8/14, that inactivates CKII. The MRP-8/14 protein complex may inhibit CKII-mediated E7 phosphorylation and therefore may alter its interaction with cellular ligands and reduce E7 oncogenic activity. We examined the inhibitory effect of the MRP-8/14 complex on CKII activity and HPV16 E7 phosphorylation. We have shown that CKII activity and HPV16 E7 phosphorylation were inhibited by uptake of exogenous MRP-8/14 and activation of endogenous MRP-8/14. MRP-8/14-mediated inhibition of E7 phosphorylation occurred at the G1 phase of the cell cycle. Analysis of MRP expression in primary keratinocytes and in HPV16- and 18-transformed cervical and foreskin epithelial cell lines showed that expression of MRP-8, MRP-14, and the MRP-8/14 complex was detected only in primary untransformed keratinocytes and not in the HPV-infected immortalized epithelial cells. CKII activity in HPV-immortalized keratinocytes was approximately fourfold higher than in HPV-negative primary keratinocytes. Treatment of HPV-positive immortalized epithelial cells with exogenous MRP-8/14 resulted in E7 hypophosphorylation and complete inhibition of cell growth within 2 weeks, compared with HPV-negative primary and immortalized HPV-negative cervical epithelial cells, which showed 25 and 40% growth inhibition, respectively. Together these results suggests that the MRP-8/14 protein complex in HPV-infected epithelial cells may play an important role in regulation of CKII-mediated E7 phosphorylation and inhibition of its oncogenic activity.
authors.affiliation: Department of Medicine, University of California, San Francisco, 513 Parnassus Ave., San Francisco, CA 94143, USA. tugizov@itsa.ucsf.edu
authors.forename: Sharof
authors.initials: S
authors.lastname: Tugizov
authors.forename: Jennifer
authors.initials: J
authors.lastname: Berline
authors.forename: Rossana
authors.initials: R
authors.lastname: Herrera
authors.forename: Maria Elena
authors.initials: ME
authors.lastname: Penaranda
authors.forename: Mayumi
authors.initials: M
authors.lastname: Nakagawa
authors.forename: Joel
authors.initials: J
authors.lastname: Palefsky
mesh_terms: D040501:Calgranulin A / Q000502:physiology*; D040502:Calgranulin B / Q000502:physiology*; D047390:Casein Kinase II / Q000037:antagonists & inhibitors; D002455:Cell Division; D002478:Cells, Cultured; D006801:Humans; D009856:Oncogene Proteins, Viral / Q000378:metabolism*; D050725:Papillomavirus E7 Proteins; D010766:Phosphorylation
chemical_list: D040501:Calgranulin A; D040502:Calgranulin B; D009856:Oncogene Proteins, Viral; D050725:Papillomavirus E7 Proteins; C059731:oncogene protein E7, Human papillomavirus type 16; D047390:Casein Kinase II